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ABSTRACT Colorectal cancer (CRC) has a complex etiology resulting from the combination of multiple
genetic and environmental factors, each with small effects. Interactions among susceptibility modifier loci
make many of the loci difficult to detect in human genome-wide association studies. Previous analyses in
mice have used classical inbred strains, which share large portions of their genomes due to common
ancestry. Herein, we used an interspecific backcross between the Mus musculus strain A/J and the Mus
spretus strain SPRET/EiJ to map 6 additional CRC modifier loci (Scc16-21) and 2 suggestive loci. Three loci
modify the location of tumors along the proximal-distal axis of the colon. Six CRC modifiers previously
mapped in intraspecific crosses were also replicated. This work confirms genetic models suggesting that
CRC is caused by many small effect alleles and brings the catalog of reported CRC modifier loci to 23
spread across 13 chromosomes. Furthermore, this work provides the foundation for large population-level






Colorectal cancer (CRC) is the third most commonly diagnosed form
of cancer in developed countries, and it is responsible for the second
largest number of cancer-related deaths. First-degree family members
of an individual with sporadic cancer have a 2- to 3-fold increased risk
of developing CRC (Bishop and Thomas 1990; Stephenson et al.
1991), indicating that shared genetic factors likely contribute to dif-
ferential susceptibility. Twin studies demonstrate that heritable factors
account for as much as 35% of sporadic CRC cases (Lichtenstein et al.
2000).
Genetic analyses in both humans and mice suggest that multiple
small-effect alleles contribute to sporadic CRC susceptibility. Recent
genome-wide association studies in humans have identified loci that
increase risk associated with CRC (Broderick et al. 2007; Houlston
et al. 2008; Jaeger et al. 2008; Tomlinson et al. 2007, 2008; Zanke et al.
2007). In an independent study, three of the loci were replicated, and
combined analysis suggested that the odds ratio is at most 2.6 for
a high-risk patient with two risk alleles among the three loci (Tenesa
et al. 2008). Similar to the variability in susceptibility of humans to
sporadic CRC, different mouse strains show varying susceptibility to
colonic tumors (Bissahoyo et al. 2005; Diwan and Blackman 1980).
The CRC susceptibility loci identified in mice have primarily been
based upon the azoxymethane (AOM) or related dimethylhydrozine
(DMH) carcinogen model (Schauer et al. 1969; Uronis and Threadgill
2009; Ward 1975). AOM induces tumors in the distal mouse colon
that resemble sporadic CRC of the descending colon in humans both
histologically (Chang 1978; Uronis et al. 2007) and molecularly (Hir-
ose et al. 2003; Kaiser et al. 2007; Takahashi et al. 2000; Vivona et al.
1993). Susceptibility to colon cancer 1 (Scc1) was one of the first low-
penetrance cancer modifiers to be successfully mapped and cloned in
mice using the AOM/DMH model (Ruivenkamp et al. 2002). An
additional 14 Scc loci have been mapped using the same recombinant
congenic panel between BALB/cHeA and STS/A strains (Moen et al.
1992, 1996; Ruivenkamp et al. 2003; van Wezel et al. 1999), and more
recently, one unnamed locus using genome-wide association in a panel
of inbred mouse strains (Liu et al. 2012). Two additional colon car-
cinogenesis susceptibility loci, Ccs1 and Ccs2, were reported in studies
using crosses between ICR/Ha and C57BL/6Ha and between CBA/J
and C57BL/6J, respectively (Angel et al. 2000; Jacoby et al. 1994).
A recent analysis of inbred mouse strains revealed that common
laboratory strains have a significant, shared contribution from Mus
Copyright © 2012 Eversley et al.
doi: 10.1534/g3.112.002253
Manuscript received February 19, 2012; accepted for publication October 3, 2012
This is an open-access article distributed under the terms of the Creative
Commons Attribution Unported License (http://creativecommons.org/licenses/
by/3.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Supporting information is available online at http://www.g3journal.org/lookup/
suppl/doi:10.1534/g3.112.002253/-/DC1
1Corresponding author: Department of Genetics, CB#7614, North Carolina State
University, Raleigh, NC 27695. E-mail: threadgill@ncsu.edu
Volume 2 | December 2012 | 1577
musculus domesticus (Roberts et al. 2007; Yang et al. 2011). The
consequence of common ancestry is that large genomic intervals are
identical by descent, resulting in reduced genetic diversity. Conse-
quently, previous studies in mice have analyzed only part of the mouse
genome for CRC susceptibility loci. SPRET/EiJ (M. spretus) diverged
from M. musculus over one million years ago and offers the potential
to analyze additional regions of the mouse genome. Using genetic
crosses between the AOM-resistant SPRET/EiJ strain and the suscep-
tible A/J strain, we mapped six additional Scc loci and two suggestive
loci influencing a variety of tumor phenotypes, including position
along the proximal-distal axis of the colon.
MATERIAL AND METHODS
Genetic crosses
A/J (A) and SPRET/EiJ (S) mice were obtained from the Jackson
Laboratory (Bar Harbor, ME). Female A/J mice (M. musculus) were
crossed to male SPRET/EiJ mice (M. spretus) to generate ASF1
hybrids. Since this interspecific cross generates infertile males, ASF1
females were backcrossed to A/J males to create a population of 235
(ASF1)A N2 mice.
Cancer phenotyping
Mice, two-to-four months of age, were given four weekly intraperi-
toneal injections of AOM at 10 mg/kg of body weight (Sigma-Aldrich,
St. Louis, MO) as previously determined to optimize differential
susceptibility to AOM-induced CRC (Bissahoyo et al. 2005). Mice
were weighed and killed by CO2 asphyxiation 20 weeks after the last
AOM dose. A tail clip, liver lobe, and the entire colon were removed
from each mouse. Colons were gently flushed with phosphate buffer
saline, mounted on bibulous paper, and splayed open along the lon-
gitudinal axis. The number of tumors, their sizes, and locations along
the proximal-distal axis were recorded.
Genotyping
DNA was extracted from liver or tail samples from each mouse using
Puregene DNA Purification Kit (Promega, Madison, WI). Mice from
the (ASF1)A N2 generation were genotyped using a custom Seque-
nom MassARRAY SNP Genotyping platform containing 183 single
nucleotide polymorphisms (SNP) markers (GeneSeek, Lincoln, NE).
The custom platform design included SNP markers from NCBI Build
37 spaced at 10–15 cM intervals selected to be informative between
Figure 1 Genome scan for modifier
loci controlling body weight. Signifi-
cance thresholds are shown by dotted
lines, and red lines mark peak LOD
scores.
Figure 2 Colon tumor penetrance of parental strains, F1 hybrids, and
N2 backcross mice used in the current study.
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the A/J and SPRET/EiJ mouse strains. All genotype and phenotype
data are provided in Supporting Information, File S1.
QTL mapping
Genotype probabilities were calculated using the Haldane map
algorithm in J/qtl software (http://research.jax.org/faculty/churchill/
software/Jqtl/index.html), a Java interface for R/qtl (Broman et al.
2003). As none of the tumor phenotypes could be transformed to
fit a Gaussian distribution when all mice were included, the binary
phenotype of presence or absence of tumors was used for the initial
analysis. Binary analysis was performed by obtaining the maximum-
likelihood estimates using the EM algorithm at 2 cM intervals
throughout the genome (Broman 2003). Mice without tumors were
excluded from further quantitative analyses. Genetic analysis of body
weight was performed on nontransformed data using all mice.
The phenotypic measurements tumor number, average tumor
diameter, maximum tumor diameter, and tumor position along the
proximal-distal colonic axis from mice with tumors (n = 113) were
transformed using rank z-transformation parameters and analyzed as
normally distributed phenotypes. One-dimensional genomes scans
n Table 1 Point-wise analysis of previously mapped colon cancer susceptibility loci
Locus SNP Marker Chr Mb Presence/Absence P-value Tumor Multiplicity P-value Tumor Load P-value
Scc1 rs3716390 2 81.6 0.55 0.81 0.41
Scc2 rs4223152 2 52.5 0.64 0.45 0.72
Scc3 rs8253293 1 196.9 0.28 0.37 0.13
Scc4 rs4231637 17 73.5 0.13 0.93 0.78
Scc5 UNC_18_37970902 18 37.9 0.66 0.02 0.02
Scc6 rs4228590 11 17.1 0.74 0.11 0.15
Scc7 / Ccs2 rs6322812 3 159.5 0.08 0.45 0.73
Scc8 rs3701395 8 3.1 0.25 0.09 0.02
Scc9 rs13480754 10 106.9 0.05 0.47 0.70
Scc10 rs16822005 2 91 0.42 0.85 0.41
Scc11 rs3024208 4 130.4 0.03 0.09 0.25
Scc12 rs16807506 7 135 0.53 0.69 0.85
Scc13 rs29973570 6 72.5 0.03 0.03 0.02
Scc14 rs6280091 10 31.4 0.54 0.66 0.87
Scc15 rs4228762 11 58 ,0.01 0.11 0.18
Ccs1 rs8261201 12 88.5 0.24 0.12 0.35
P-values lower than 0.05 are marked in bold.
Figure 3 Genome scan for modifier loci controlling the binary tumor presence phenotype. Significance thresholds are shown by dotted lines, and
red line marks peak LOD score. Inset shows allele effect plot of the peak marker on Chr 11.
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were performed using the EM algorithm. Tumor load (tumor number
· average tumor diameter) could not be transformed to fit a normal
distribution and was analyzed using an extension of the Wilcoxon
rank sum test for non-parametric interval mapping (Broman 2003;
Kruglyak and Lander 1995). No secondary loci were detected in any of
the one-dimensional genome scans when controlling for the primary
locus that was detected in each analysis. Only loci that reached ge-
nome-wide significance were given official designations.
Two-dimensional analysis of tumor phenotypes was performed
using Haley-Knott regression algorithms to identify epistatic inter-
actions. Significance thresholds were calculated by performing 1000
permutations with intervals set at the 182 SNP markers used in the
analysis. The additive and interaction models were used to determine
the type of epistasis influencing phenotypic variance.
Pointwise Wilcoxon rank sum test was performed on SNP markers
in close proximity to previously identified Scc loci (Moen et al. 1992,
1996; Ruivenkamp et al. 2003; van Wezel et al. 1999).
RESULTS
Validation of the A/J · SPRET/EiJ cross for
modifier mapping
To validate the utility of the interspecific backcross population for
mapping modifiers of CRC susceptibility, modifier loci controlling
body weights of (ASF1)A N2 mice were analyzed, and their locations
were compared with previously identified obesity modifiers in SPRET/
EiJ crosses. Loci on Chr 7 (Mob1) and Chr12 (Mob3), originally
reported in a (C57BL/6J · SPRET/EiJ) · C57BL/6J backcross (Fisler
et al. 1993; Warden et al. 1995; Yi et al. 2004), were replicated (Figure
1). Additionally, two previously reported body weight modifiers on the
X chromosome (Bw1 and Bw3) were replicated. Bw1 and Bw3 were
previously reported in (A/J · SPRET/EiJ) · C57BL/6J and (C3H/He ·
SPRET/EiJ) · C57BL/6J crosses, respectively (Dragani et al. 1995).
Replication of previously mapped Scc loci
When exposed to four weekly doses of AOM, 100% of A/J mice
developed colonic tumors, whereas SPRET/EiJ mice were completely
resistant (Figure 2). Genome-wide, SPRET/EiJ is dominant to the
susceptible A/J strain, as less than 5% of ASF1 hybrids develop
tumors. Almost 50% of the (ASF1)A N2 backcross mice (113 of
235) developed colorectal tumors in response to AOM exposure.
To determine whether previously mapped colon tumor suscepti-
bility loci also contribute to differential susceptibility in the (ASF1)A
N2 population, point-wise analysis was performed using the SNP
marker nearest to previously identified Scc and Ccs loci (Table 1)
(Angel et al. 2000; Jacoby et al. 1994; Moen et al. 1992, 1996; Rui-
venkamp et al. 2003; van Wezel et al. 1996, 1999). Markers near Scc9,
Scc11, Scc13, and Scc15 showed significant association with tumor
presence, whereas Scc5 and Scc13 were associated with tumor number
and tumor load. Scc8 was only associated with tumor load. No other
Scc or Ccs loci showed an association with colon tumor phenotypes in
the (ASF1)A N2 population, and none of the previously mapped loci
reached significance when performing a genome-wide analysis, con-
sistent with being low-effect susceptibility alleles. Since SNPs were not
selected based on location of previous colon cancer susceptibility loci,
some markers were more distant, resulting in reduced power to rep-
licate previous results.
SPRET/EiJ harbors a major colon cancer resistance locus
Binary analysis of tumor presence ($1 tumor, n = 113 mice) and
absence (0 tumors, n = 125 mice) detected a single modifier locus
(LOD = 3.83; Figure 3). This locus, designated Scc16 (Table 2), was
n Table 2 Summary of colon cancer modifier loci identified in an (ASF1)A N2 backcross
Locus Phenotype SNP Marker Chr Mba Conf Int (cM)b LOD Score P-value
Scc16 Tumor presence rs16808928 11 116.4 32.0–71.0 3.83 ,0.01
Scc17 Tumor number rs13479769 8 55.6 12.0–70.8 2.66 0.04
Chr 1 Tumor number rs3658044 1 19.2 0–20.0 2.291 0.11
Scc18 Tumor load rs16805672 6 88.7 36.2–58.7 2.825 0.04
Scc19 Max tumor size ·
sex/tumor load
rs13482118 14 30.6 5.8–20.2 3.389 0.05
Scc20 Rel distal position ·
tumor number
rs8238935 1 58.1 9.1–34.5 4.067 ,0.01
Full / Additive Alpha
Scc17 · Scc21 Tumor load rs13479769 · rs16810780 8 · 1 55.6 · 34.5 5.565 / 4.581 0.10
Scc18 · Scc19 Tumor load · sex rs16805672 · rs13482118 6 · 14 88.7 · 30.6 6.236 / 6.190 0.05
Full / Interaction Alpha
Chr 1 · Chr 10 Rel distal position ·
tumor number
rs3658044 · NCBI_10_99187828 1 · 10 19.2 · 99.1 7.358 / 6.351 0.10
a
Physical location of SNP markers.
b
1.5 LOD confidence intervals based on genetic analysis.
n Table 3 Tumor phenotype correlation matrix
r2 Tumor Load Max Tumor Diameter Avg Tumor Diameter Relative Position Tumor Number
Tumor load 1.00 0.68 0.50 0.47 0.89
Max tumor diameter 1.00 0.86 0.31 0.47
Avg tumor diameter 1.00 0.17 0.23
Relative position 1.00 0.45
Tumor number 1.00
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most strongly associated with rs16808928 (Chr 11, 71 cM). A tumor
effect plot revealed that SPRET/EiJ contributes a tumor-resistance
allele at Scc16 (Figure 3, inset); mice heterozygous at rs16808928 have
a significantly increased likelihood of being tumor free than mice
homozygous for the A/J allele (t test, P , 0.0001).
Colorectal cancer phenotypes are determined by
oligogenic modifier loci
Mice without tumors were excluded from analysis of quantitative tumor
phenotypes, including tumor number, tumor load, average tumor
diameter, maximum tumor diameter, and tumor position along the
colon, phenotypes that are weakly correlated within the (ASF1)A N2
backcross population (Table 3). Only average tumor diameter and max-
imum tumor diameter, as well as tumor number and tumor load have r2
values greater than 0.7. The fact that average tumor size was not corre-
lated with tumor load, which is the product of average tumor size and
tumor number, suggests that tumor number is much more variable than
average tumor diameter and is the major determinant of tumor load.
Tumor number is the only phenotype that was not transformable
into a normal distribution. Non-parametric methods detected a single
modifier on Chr 8 named Scc17 (rs13479769, 30 cM; LOD = 2.66;
Table 2), which explains 10.1% of the variance in tumor number (P =
0.001). An effect plot revealed that mice heterozygous at the Scc17
locus have fewer tumors than mice homozygous for the A/J allele (t
test, P = 0.0003), showing that the A/J allele increases tumor number.
An additional putative tumor number modifier on Chr 1 (rs3658044)
was suggestive; this locus potentially explains 7.6% of the phenotypic
variance (P = 0.003).
Analysis of tumor load also identified one modifier on Chr 6
named Scc18 (rs16805672, 37 cM; LOD = 2.826; Table 2), which
explains 11.4% of the variance (P , 0.0001). Interestingly, the
SPRET/EiJ Scc18 allele increases tumor load. No loci were detected
that modified average or maximum tumor diameter. However, a sex-
dependent modifier locus on Chr 14 named Scc19 was detected for
maximum tumor size (LOD = 3.421); Scc19 explains less than 1% of
the variance (P = 0.325).
The colon has a proximal-distal axis with regional differences in cell
composition and function. Modifiers influencing tumor position within
the colon have not been reported. To identify whether modifiers
influence tumor position, a genome scan was performed using
measurements of tumor position along the proximal-distal axis of the
colon. Although no significant associations were detected using tumor
position alone, if tumor number were considered as a covariate, one
modifier named Scc20 was identified on Chr 1 (rs8238935, 32 cM; LOD
= 4.067; Figure 4). This locus is proximal to the suggestive tumor
number modifier Chr 1 (rs3658044) with an overlapping confidence
interval; however, it is likely to be a distinct locus because the r2 cor-
relation between tumor number and position is only 0.45 (Table 3).
Mice homozygous for the A/J Scc20 allele are likely to have tumors that
are positioned more distally than mice heterozygous at the Scc20 locus.
Epistatic interactions among modifiers
Two-dimensional modifier scans were performed on all tumor
phenotypes to detect allele combinations that may have gone
undetected using one-dimensional scans. Analysis of tumor load
revealed one significant (a = 0.05) and one suggestive interaction (a =
0.1; Figure 5 and Table 2). The suggestive additive interaction was
detected between Chr 8 (Scc17) and a locus on Chr 1 named Scc21
(full LOD = 5.565, and additive LOD = 4.581). An effect plot of tumor
load shows that the tumor load–increasing effect of the A/J allele at
Scc21 is observed only when mice are also homozygous for the A/J
allele at Scc17 (Figure 5, inset). A larger study will be required to
validate putative epistatic interactions between loci on Chrs 1 and 6,
Chrs 6 and 8, and Chrs 6 and 18 that do not reach the suggestive
threshold set for interactions (Figure 5), as well as for the detection of
interactions previously reported such as between Ssc7 and Scc8 (van
Wezel et al. 1996).
When sex was used as a covariate with tumor load, a significant
interaction was detected between Scc18 and Scc19 (full LOD = 6.236,
and additive LOD = 6.190, Table 2).
A suggestive interaction was also detected for tumor position, but
only if tumor number was used as a covariate (Table 2). The
Figure 4 Genome scan for modifier
loci controlling the tumor number
phenotype. Significance thresholds
are shown by dotted lines, and red
line marks peak LOD score.
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interaction LOD between (rs3658044) and a locus on Chr 10
(NCBI_10_99187828) is 7.358 (full–add).
DISCUSSION
Several loci influencing CRC susceptibility have been identified in
crosses between resistant and susceptible mouse strains. Numerous
studies using recombinant congenic strains led to the identification of
15 Scc loci, with almost half being involved in two-way interactions
(Moen et al. 1992, 1996; Ruivenkamp et al. 2003; van Wezel et al.
1996, 1999). Analyses of additional crosses were used to identify Ccs1
and Ccs2 (Angel et al. 2000; Jacoby et al. 1994). We employed an
interspecific backcross to replicate six of the previously reported loci
and to identify six additional loci, Scc16–21 (Figure 6). This brings the
number of reported colon cancer susceptibility loci in mice to 23
spread across 13 chromosomes, with half of the known loci being
detected in the interspecific backcross reported here. Similar to
Figure 5 Heat plot of two-dimensional genome scan for tumor load modifiers. Color scale represents significance levels. The image above the
diagonal is the additive portion of allele effect and below the diagonal is the full allele effect. Inset shows effect plot of the interaction detected
between Chr 8 and 1 (Scc17 · Scc21).
Figure 6 Comparative locations of all
reported colon cancer susceptibility
loci. Each locus is centered in its
confidence interval.
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previous observations, numerous interactions between modifiers were
observed, suggesting that networks of interacting, low-penetrance
alleles determine CRC susceptibility. The small effect of most modi-
fiers highlights the difficulties involved in identifying allelic combina-
tions that influence cancer susceptibility in humans and that likely
contributed to several previous modifier loci not replicating in the
current study. Lack of replication could also be due to genetic differ-
ences among the strain combinations used and/or Type I errors.
A recently reported genome-wide association study using an
intrasubspecific panel of mouse strains also replicated some previously
detected Scc and Ccs loci (Liu et al. 2012), although only one, Scc8, was
in common with the present study. The lack of concordance across the
three approaches (intrasubspecific linkage, intrasubspecific association,
and intersubspecific linkage) underscores the difficulties in detecting
low-penetrance allele effects and the variation in loci detected that is
dependent upon the genetic structure of the target populations.
Genome-wide analysis of an interspecific backcross between SPRET/
EiJ and A/J reported here detected a locus (Scc16) with a major effect
controlling penetrance of AOM-induced tumors. Tumor load was most
strongly influenced by Scc18 located on Chr 6. Furthermore, Scc17,
modulating tumor number, and Scc21 were found to interact to affect
tumor load. Tumor load is also regulated in a sex-dependent fashion by
Scc19, which was detected individually using maximum tumor diameter.
Modifiers also appear to influence the relative position of tumors
along the proximal-distal axis of the colon. Scc20 on Chr 1 and an
interaction between suggestive loci on Chr 1 (rs3658044) and Chr 10
(NCBI_10_99187828) modify spatial positioning of tumors. Chr 10
(NCBI_10_99187828) is proximal to Scc9 with both loci being located
in a region of conserved synteny with human Chr 12. Interestingly,
several studies report hypermethylation, overexpression, and chromo-
somal loss of genes associated with colon cancer on 12q (Nakao et al.
1998; Richter et al. 2003; van Dieren et al. 2006). The detection of Chr
10 (NCBI_10_99187828) in the present study increases the possibility
that one or both of these loci represent alleles whose orthologs may be
associated with cancer susceptibility in humans.
A number of genome-wide association studies have been con-
ducted recently in humans, which revealed several common variants
that function as low-penetrance susceptibility alleles. Although none
of the mouse susceptibility loci identified here appear to be in
conserved syntenic segments with those detected in the human
studies, the mouse loci may function in similar pathways or may be
detectable only when allele interactions are tested. Future identifica-
tion of the underlying genes responsible for the Scc loci should reveal
the relationship between mouse and human cancer susceptibility and
how genetic modifiers influence susceptibility.
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